A multiscale NeuroAI model tackles why a sleeping pill can briefly restore consciousness in brain-injured patients

Guillaume Dumas’s group uses a model spanning molecules, neurons, circuits and clinical outcomes to study the zolpidem paradox in disorders of consciousness.